Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Meyran

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Genome Medicine|April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancerChelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Haematologica|June 30, 2022
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cellsKelden Richardson, Simon P Keam, Joe Jiang Zhu, et al.
Nature Communications|May 29, 2021
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacyLauren Giuffrida, Kevin Sek, Melissa A Henderson, et al.
Cancer Discovery|May 15, 2021
CDK4/6 Inhibition Promotes Antitumor Immunity through the Induction of T-cell MemoryEmily J Lelliott, Isabella Y Kong, Magnus Zethoven, et al.
Science Translational Medicine|April 5, 2023
T<sub>STEM</sub>-like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical modelsDeborah Meyran, Joe Jiang Zhu, Jeanne Butler, et al.
Nature Communications|July 3, 2025
Tumor site-directed A1R expression enhances CAR T cell function and improves efficacy against solid tumorsKevin Sek, Amanda X Y Chen, Thomas Cole, et al.
Genome Medicine|April 4, 2023
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancerChelsea Mayoh, Andrew J Gifford, Rachael Terry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 2